Glucotrack seeks FDA approval for clinical study of CBGM technology
Glucotrack will proceed with the planned US trial after the FDA reviews and approves the IDE application.
Educating the medical device manufacturing industry since 2002.
Glucotrack will proceed with the planned US trial after the FDA reviews and approves the IDE application.
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns